Biomedical Sealant Market

Biomedical Sealant Market – Trends, Outlook, and
Opportunity Analysis, 2018 – 2026
Biomedical sealants have emerged as a promising product for replacing staples and sutures to
prevent liquid and air leakages after and during surgeries. Surgical sealants are made from
synthetic or natural polymers or a combination of both. Sealant materials are required to be
elastic and compliant with the tissue to allow movement and function of various tissues of
lungs, blood vessel, skin, and heart.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/1936
These materials include polyurethane, glycol, and polyethylene glycol or naturally occurring
polysaccharides or proteins. Polyurethane is used in biomedical sealants due to its property of
strong adhesion and high elasticity to tissues. Polyethylene glycol in sealants is widely used as
hemostatic adhesive and fluid barrier.
Synthetic biomedical sealants have higher mechanical strength and tissue bonding properties as
compared to natural biomedical sealants. These physical properties and adhesion strength are
some key factors of implementing biomedical sealants to seal the wound area without causing
any hindrance to the function and movement of tissues. Surgical sealants are used commonly to
prevent leakage of any fluid or air from a surgical incision.
Report includes chapters which deeply display the following deliverable about industry :
• Biomedical Sealant Market Research Objective and Assumption
• Biomedical Sealant Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Biomedical Sealant Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Biomedical Sealant Market, By Regions
• Biomedical Sealant Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Biomedical Sealant Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Biomedical Sealant Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Biomedical Sealant Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Biomedical Sealant Market Drivers:Approval of new biomedical sealants in key regions such as Europe is expected to drive growth
of the biomedical sealant market. For instance, in 2017, Starch Medical, marketer and
manufacturer of polysaccharide-based hemostatic products such as biomedical sealants was
approved by C.E. Mark for Super Clot. Post the approval, company has planned to utilize their
existing network of distribution partners along with their new strategic partners to bring Super
Clot to hospitals and surgical teams throughout Europe. This strategic planning of product
distribution is expected to fuel growth of the global biomedical sealant market.
Mergers and acquisitions by key players is also another factor expected to support the global
biomedical sealant market growth. For instance, in January 2018, Baxter International Inc., a
U.S.-based healthcare company, acquired two surgical products i.e. Recothrom and Preveleak of
Mallinckrodt Pharmaceuticals—a producer of specialty pharmaceutical products. Recothrom is a
thrombin based topical product, which is designed to assist hemostasis, this product is used
when surgical methods to prevent flow of blood is ineffective in adults and pediatrics. Preveleak
is a surgical sealant used to close suture holes to obtain hemostasis during surgical vascular
reconstructions.
Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1936
Non-availability of one sealants, which provide stiffness, elasticity, and high adhesion together,
is a major restraining factor for growth of the market. For instance, though fibrin-based sealants
do offer good elasticity, these offer low stiffness and adhesion. Cyanoacrylates have high
adhesion and stiffness, however, offer low elasticity. These factors could negatively impact
growth of the market over the forecast period.
Biomedical Sealant Market Regional Analysis:North America is expected to be dominant in the global biomedical sealant market over the
forecast period. This is due to increasing product launches by key players in the region. For
instance, in 2017, Starch Medical, a marketer and manufacturer of polysaccharide-based
hemostatic products such as biomedical sealants, launched its new product Super Clot. Super
Clot is a biomedical sealant used for effective and rapid hemostasis. Such new products in the
market are expected to boost growth of the North America biomedical sealant market.
Europe biomedical sealant market is also expected to exhibit significant growth over the forecast
period. This is due to increasing number of approvals for new products by Certification Marking
(C.E. Mark). For instance, in 2017, Gecko Medical, a medical device company which develops
innovative polymers to support reconstruction of tissue, announced C.E mark approval for its
product SETALUM sealant.
SETALUM sealant is bio-reabsorb able, biocompatible, and can also be used in dynamic and wet
environments such as blood as an add-on to sutures during vascular surgeries. This sealant is
applied to tissue in an appropriate position and is further activated using a light activation pen.
This sealant is easily applicable due to its viscosity and hydrophobicity..
Biomedical Sealant Market Key Players:Key players operating in the global biomedical sealant include Bostik, 3M Company, Henkel AG
& company, KGaA., CryoLife Inc., Chemence Ltd., Cyberbond LLC., Ethicon Inc., Covidien PLC.,
Glustitch Inc., Adhezion Biomedical LLC., Cohera Medical Inc., Baxter International Inc., Meyer
Haake GmbH, Angiotech Pharmaceuticals Inc., and Biocoral Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Biomedical sealants have emerged as a promising product for replacing staples and sutures to prevent liquid and air leakages after and during surgeries.

Download Report